Salivary Estradiol ELISA
Recall Z-2836-2018, part of FDA recall event 80575. See DRG Instruments's company page.
DRG Instruments GmbH started this Class II device recall on Jul 14, 2016 (voluntary: firm initiated); FDA lists it as terminated, terminated Aug 4, 2020.
- Classification: Class II
- Started: Jul 14, 2016
- Status: Terminated
Lower recovery of salivary estradiol levels due to poor differentiation between kit Standard 0 and Standard 1.
- Product
- Salivary Estradiol ELISA, REF SLV-4188 in vitro diagnostic quantitative measurement of active free Estradiol, an estrogenic steroid, in saliva.
- Quantity
- 169 kits
- Lots and codes
- Lot # 68K056 Exp. Date 2017-05
- Distribution
- NJ; Germany, Belgium, Spain & Germany
- Recalling firm
- DRG Instruments GmbH, Marburg, Germany
- How the firm notified
- Letter
- FDA classified
- Aug 16, 2018
Newest first, one product per recall event; search them all
- DRG Salivary Progesterone HS ELISA- IVD for the determination of progesterone in human saliva REF: SLV-5911 in…Z-2410-2019 · Class II · Jun 6, 2019 · Terminated
- DRG Salivary Testosterone ELISA- IVD for the detection of Testerone in human saliva Catalog # SLV-3013 Product…Z-2159-2019 · Class II · May 21, 2019 · Terminated
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports